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Abstract
Background: Simultaneous use of alcohol and cannabis predicts increased negative consequences
for users beyond individual or even concurrent use of the two drugs. Given the widespread use of
the drugs and common simultaneous consumption, problems unique to simultaneous use may bear
important implications for many substance users. Cognitive expectancies offer a template for future
drug use behavior based on previous drug experiences, accurately predicting future use and
problems. Studies reveal similar mechanisms underlying both alcohol and cannabis expectancies,
but little research examines simultaneous expectancies for alcohol and cannabis use. Whereas
research has demonstrated unique outcomes associated with simultaneous alcohol and cannabis
use, this study hypothesized that unique cognitive expectancies may underlie simultaneous alcohol
and cannabis use. Results: This study examined a sample of 2600 (66% male; 34% female) Internet
survey respondents solicited through advertisements with online cannabis-related organizations.
The study employed known measures of drug use and expectancies, as well as a new measure of
simultaneous drug use expectancies. Expectancies for simultaneous use of alcohol and cannabis
predicted simultaneous use over and above expectancies for each drug individually.
Discussion: Simultaneous expectancies may provide meaningful information not available with
individual drug expectancies. These findings bear potential implications on the assessment and
treatment of substance abuse problems, as well as researcher conceptualizations of drug
expectancies. Policies directing the treatment of substance abuse and its funding ought to give
unique consideration to simultaneous drug use and its cognitive underlying factors.
Background
Expectancies represent intervening cognitive variables that
connect memory and behavior, and reflect knowledge of
a relationship between events and objects [1]. Bolles [2]
identified expectancies as environmental stimulus-out-
come contingencies that directly affect behavior, and
regarded expectancies as synonymous with the concept of
association. Expectancies represent individual learning
associations made between stimuli, individual responses
and resulting outcomes. Heavy drug consumers may be
more likely to activate positive expectancies for drug
effects [e.g. [3]].
While researchers have investigated the cognitive mecha-
nisms underlying single substance use [e.g. [4]], a relative
dearth of research exists on the cognitive mechanisms
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informing simultaneous polydrug use or their role in drug
abuse. Research suggests that similar mechanisms may
underlie expectancies for both alcohol and cannabis use.
Stacy [5] demonstrated that similar memory association
mechanisms underlie both alcohol and cannabis use.
Boys and Marsden [6] found that polysubstance users'
expectations regarding relief of negative mood states
increased the likelihood to use drugs such as cannabis and
alcohol simultaneously. Yet no studies assess simultane-
ous drug use expectancies, despite findings that simulta-
neous use of cannabis and alcohol may yield different
outcomes than use of cannabis alone [e.g. [6]].
Researchers identify cannabis and alcohol as the two sub-
stances most frequently used simultaneously [7,8]. The
simultaneous use of alcohol and cannabis may introduce
greater problems than the use of both drugs independ-
ently or even concurrently. Staines et al [9] reported a pos-
itive relationship between problems with alcohol and
simultaneous use of illicit drugs such as cannabis. Other
studies link simultaneous cannabis and alcohol use with
increased negative consequences such as psychological
distress, psychopathology [10] and substance dependence
[9].
Earleywine and Newcomb [7] distinguished between con-
current drug use (e.g. use on separate occasions) and
simultaneous use of multiple drugs, and found the two
types of use form two distinct constructs. Simultaneous
polydrug users may experience greater psychological dis-
tress and other negative consequences associated with
drug use compared to other substance users [11,12].
Smucker Barnwell et al [13] found that interactions
between measures of cannabis use and alcohol consump-
tion significantly predicted cannabis dependence among
frequent cannabis users. Stenbacka [14] found that simul-
taneous use of alcohol and cannabis among adolescents
predicted later problems with either drug. Alcohol use and
abuse serve as primary predictors of cannabis dependence
[15-17], and cannabis dependence covaries more with
alcohol dependence than with most other psychiatric
diagnoses [18]. Similarly, several studies find that canna-
bis use frequently occurs among individuals with alcohol
dependence diagnoses [18]. Heavy alcohol consumption
among cannabis users may result in more problematic
cannabis use, less successful cessation and more resulting
negative life consequences [19].
The present research also sought to understand the etiol-
ogy underlying the increased risks associated with simul-
taneous polydrug use. The interaction of alcohol and the
chemical component known to cause the majority of can-
nabis' intoxicating effects, delta-9 tetrahydrocannabinol
(THC), may offer a pharmacological explanation. Lukas
and Orozco [20] found that smoking cannabis while also
consuming ethanol lead to increased THC levels in the
blood and more intensely positive reported subjective
effects. Individuals who consume both drugs simultane-
ously may experience higher absorption rates of THC,
increased positive effects of the drug, and, perhaps, greater
cannabis or even alcohol dependence symptoms. Outside
of pharmacological explanations, researchers posit that
expectancies play a major role in the prediction of sub-
stance use and abuse [e.g. [5]].
Whereas different behavioral outcomes are predicted for
simultaneous use of cannabis and alcohol, it seems plau-
sible that unique cognitive expectancies underlie these
outcomes. Individuals using several drugs simultaneously
seem likely to possess different expectancies than an indi-
vidual using a single substance. Perhaps these individuals
possess unique cognitive templates that inform simulta-
neous polydrug use. Beyond individual drug expectancies,
this study sought to identify unique cognitive constructs
motivating simultaneous drug use. Perhaps simultaneous
alcohol and cannabis use possess a distinct and unique set
of expectancies, predicting simultaneous use beyond indi-
vidual drug expectancies. This study examined whether
simultaneous alcohol and cannabis use expectancies
more accurately predicted simultaneous cannabis and
alcohol use than single substance expectancies alone.
Since little research exists on the identification and meas-
urement of simultaneous drug use expectancies, this
project offers a unique contribution to the existing litera-
ture on substance use and its motivators. Researchers and
policy makes alike stand to benefit from greater under-
standing of usual patterns of drug use, their precipitating
factors and, by extension, pathways to intervention and
even prevention.
Results
Participants
Members of the Marijuana Policy Project (MPP) and
National Organization for the Reform of Marijuana Laws
(NORML) listserves received an email requesting survey
participation. The study focused on individuals consum-
ing cannabis and alcohol at least once a month to ensure
sufficient information regarding target behaviors (N =
2637). Two thirds of respondents were male (66%); one
third was female (34%). Respondents ranged in age from
13 to 86. Their mean age was 34.0 years (SD = 13.3). The
average respondent first tried cannabis at the age of 16.0
years (SD = 3.9). The group was primarily of European
descent, with other ethnicities ranking far behind. The
majority of respondents possessed a Bachelor's degree,
Associate's degree, or some college credit completion. The
average participant earned an annual income of less than
$40,000 (See Table 1). All participants completed an
online consent form in accordance with university ethical
procedures. To ensure participant confidentiality,Substance Abuse Treatment, Prevention, and Policy 2006, 1:29 http://www.substanceabusepolicy.com/content/1/1/29
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respondents were not required to provide any identifying
information. Those participants who wished to enter into
a raffle for one of several $100 gift certificates could pro-
vide an email address. Email addresses were immediately
disconnected from all participant data to ensure respond-
ent anonymity.
Alcohol consumption measures
The average respondent consumed 44.2 drinks per month
(SD = 55.4) when consuming any alcohol. This score
derived from a measure inquiring about average incidents
of drinking per month, and usual numbers of drinks per
incident. When drinking alcohol and consuming canna-
bis together within three hours of each other (e.g. only
alcohol and cannabis), the average participant consumed
fewer (M = 28.7; SD = 49.4) drinks per month. In contrast,
when drinking only alcohol (e.g. with no other sub-
stances), respondents reported drinking still fewer (M =
20.5; SD = 42.3) drinks per month (See Table 2).
Respondents reported different amounts of alcohol when
drinking only alcohol, alcohol with cannabis and alcohol
with any other substance (See Table 3).
Cannabis consumption measures
Respondents used cannabis in any combination (e.g.
alone, with other substances) an average of 22.4 days per
month (SD = 10.3). They consumed approximately three
quarters of an ounce of cannabis per month (2.8 on a 5-
point scale; SD = 1.5, < 1/4 ounce). When using only can-
nabis, they used cannabis fewer (M = 19.1; SD = 10.8)
days per month, and tended to consume less cannabis (M
= 2.6, > 1/2 oz; SD = 1.4 < 1/4 oz). When using cannabis
and alcohol together within three hours of each other,
however, respondents consumed cannabis the fewest (M
= 7.8; SD = 8.6) days per month and in the least amounts
(M = 1.9, about 1/4 ounce; SD = 1.3, < 1/4 oz) (See Tables
4 and 5).
Simultaneous consumption measures
Participants then completed the Simultaneous Polydrug
Use Questionnaire [DUQ; 21]. The DUQ assessed fre-
quency of use of alcohol/drug and drug/drug combina-
tions among seven classes of drugs: alcohol, cannabis,
cocaine, opiates, sedatives, stimulants and hallucinogens.
The use of this measure permitted the researcher to exam-
ine patterns of simultaneous drug use outside of cannabis
and alcohol combinations. Simultaneous use was defined
as use of two or more substances occurring within three
hours of each other. Approximately one quarter of
respondents reported consuming drug combinations
other than alcohol and cannabis.1 Removal of participants
using drug combinations other than alcohol and cannabis
did not alter findings. The majority of these respondents
reported consuming marijuana with hallucinogens at
least once a month in the past four-months. Other drug
combinations were significantly less common (See Table
4).
Explicit measures of alcohol expectancies
Participants completed subscales of the Alcohol Expect-
ancy Questionnaire [AEQ; 22], a widely used 120 item
self-report questionnaire for measuring alcohol expectan-
cies. The scale demonstrates predictive and concurrent
validity and is the most commonly used measure for alco-
hol expectancies. The AEQ consists of six subscales: global
positive changes, sexual enhancement, social and physical
pleasure, social assertiveness, relaxation, and arousal/
aggression. To reduce participant burden, the study
employed only global positive changes and relaxation
subscales. Consistent with the measure's intent, we altered
the measure instructions to indicate that items referred to
the effects of alcohol use only. The measure demonstrated
high internal consistency as measured by Cronbach's
alpha (α = .89). Respondents endorsed 13.7 (SD = 7.4)
alcohol expectancy items out of a possible score of 37,
indicating moderate expectancies regarding the positive
effects of alcohol.
Explicit measures of cannabis expectancies
The Marijuana Effect Expectancy Questionnaire [MEEQ;
23] measured explicit expectancies regarding cannabis
consumption. The complete measure consists of 78 true/
Table 1: Demographics as measured by frequencies
Ethnic Group (N = 2580)
European descent 91%
Latino 4%
African descent 2%
Asian descent 1%
Mixed ethnicity 1%
Other ethnic groups (e.g. Native American, Middle Eastern) 1%
Highest Level of Education (N = 2635)
Some high school completed 4%
High School diploma 11%
Some college credit completed 39%
Associate's degree 12%
Bachelor's degree 23%
Master's degree 7%
Degree beyond Master's training 4%
Income Range (N = 2529)
Less than $20,000 per year 35%
$20,000–$40,000 29%
$40,000–$60,000 16%
$60,000–$80,000 7%
$80,000–$100,000 4%
$100,000+ 4%Substance Abuse Treatment, Prevention, and Policy 2006, 1:29 http://www.substanceabusepolicy.com/content/1/1/29
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false items and six subscales: (a) cognitive and behavioral
impairment, (b) relaxation and tension reduction, (c)
social and sexual facilitation, (d) perceptual and cognitive
enhancement, (e) global effects, and (f) craving and phys-
ical effects. To reduce participant burden, the study
employed only the relaxation and tension reduction sub-
scale and global effects subscale. Altered measure instruc-
tions clarified that the questions referred to the effects of
only cannabis use. The relaxation (α = .86) and tension
reduction subscales (α = .72) each demonstrated sound
internal consistency in the sample. Analyses employed a
combined expectancy score. Respondents endorsed 15.6
(SD = 2.3) cannabis expectancy items out of a total of pos-
sible score of 19, indicating high expectancies regarding
positive effects of cannabis.
Explicit measure of simultaneous alcohol and cannabis use 
expectancies
Using the Alcohol Expectancy Questionnaire (AEQ) and
the Marijuana Effect Expectancy Questionnaire (MEEQ),
the researcher developed a measure of expectancies for
simultaneous cannabis and alcohol use. First, the measure
repeated all previous AEQ items. If participants endorsed
the item, an additional question followed: "How does
marijuana alter this effect?" The measure employed a Lik-
ert-type scale ranging from -3 (Make it less intense) to 3
(Makes it more intense). Thus respondents reported how
alcohol impacted their experiences, and then indicated if
simultaneous cannabis and alcohol impacted their experi-
ences differently. Next, items from the MEEQ subscales
also repeated. Again, if subjects endorsed the item, the
question "How does alcohol alter this effect?" appeared.
Thus respondents indicated how cannabis impacted
them, and indicated if simultaneous cannabis and alcohol
impacted them differently. Total scores were derived by
assigning natural number analogs to scale value (e.g. 1–
7), and summing the scores. Items not endorsed the sec-
ond administrations of the AEQ and MEEQ were not
given the follow-up question (e.g. "How does alcohol/
cannabis alter this effect" and were thus not included in
their respective summary scores for simultaneous expect-
ancies. We believe that this scoring method is approxi-
mately consistent with the original expectancy measure
scoring which excludes items not endorsed from total
expectancy scores. Lower scores indicated a lesser belief
that simultaneous use intensified the experience, while
higher numbers indicated a greater belief that simultane-
ous use intensified drug use experiences.
After several phases of revisions, pilot group participants
ultimately indicated that the measure was clear and com-
prehensible. The first administration of the AEQ corre-
Table 3: Paired T-tests comparing drug use
Alcohol/Cannabis Pairs Mean SD Relevant t values
All Alcohol Per Month M = 42.4 SD = 55.4 t(2573) = 24.0**
Only Alcohol Per Month M = 20.47 SD = 42.3
All Alcohol Per Month M = 42.4 SD = 55.4 t(2574) = 16.3**
Simultaneous Drinks Per Month M = 28.7 SD = 49.4
Only Alcohol Per Month M = 20.47 SD = 42.3 t(2558) = 8.1**
Simultaneous Drinks Per Month M = 28.7 SD = 49.4
All Cannabis Per Month M = 2.8 SD = 1.5 t(2585) = 3.4**
Only Cannabis Per Month M = 2.6 SD = 1.3
All Cannabis Per Month M = 2.8 SD = 1.5 t(2572) = 32.4**
Simultaneous Cannabis Per Month M = 1.9 SD = 1.3
Only Cannabis Per Month M = 2.6 SD = 1.3 t(2543) = 29.4**
Simultaneous Cannabis Per Month M = 1.9 SD = 1.3
Note. * p < .05. ** p < .01
Table 2: Alcoholic Drinks Per Month and Ounces Cannabis Consumption Overview
Alcohol/Cannabis Mean SD Range
All Alcohol Per Month (N = 2618) M = 42.4 SD = 55.4 .5 – 625 drinks
Only Alcohol Per Month (N = 2594) M = 20.5 SD = 42.3 0 – 620 drinks
Simultaneous Drinks Per Month (N = 2744) M = 28.7 SD = 49.4 0 – 600 drinks
All Cannabis Per Month (N = 2627) M = 2.8 SD = 1.5 < 1/4 oz – >1 oz (1–5)
Only Cannabis Per Month (N = 2591) M = 2.6 SD = 1.3 < 1/4 oz- >1oz (1–5)
Simultaneous Cannabis Per Month (N = 2577) M = 1.9 SD = 1.3 < 1/4 oz – >1 oz (1–5)
Note: Metric weight of cannabis measured on 5-point scale (1 = <1/4 oz; 2 = 1/4–1/2 oz; 3 = 1/2–3/4 oz; 4 = 3/4–1 oz; 5 = >1 oz).Substance Abuse Treatment, Prevention, and Policy 2006, 1:29 http://www.substanceabusepolicy.com/content/1/1/29
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lated very highly, but not perfectly with the second
administration (N = 2635, r = .85, p < .001). The second
administration of the MEEQ correlated only moderately
with the first administration (N = 2634, r = .44, p < .001).
The measure demonstrated sound internal consistency in
the online sample (α = .81). Scores were derived from
respondents' report of how one substance impacted the
intensity of the other on the 7-point scale. Higher scores
indicated increased belief that simultaneous use of the
two substances made the experience more intensely posi-
tive. The average respondent reported a low to moderate
simultaneous expectancy score (M = 89.6; SD = 51.6).
Summed, standardized component scores served as an
index of total expectancies that consumption of one sub-
stance would alter experiences with the other.
Correlations
Large, significant correlations emerged between the vari-
ous measures of alcohol consumption. Similarly, signifi-
cant correlations emerged among measures of cannabis
consumption. Cannabis and alcohol expectancy scores
demonstrated small but significant correlations with alco-
hol and cannabis consumption measures (See Table 5).
Regressions
The first linear regression equation examined alcoholic
drinks consumed per month when also using cannabis as
the dependent variable. Lognormal transformations
improved the skew of the dependent variable [24]. The
skewness and kurtosis statistics of the measure were 4.3
and 27.4, respectively, prior to lognormal transformations
and -.03 and -.91 afterwards. Age and gender acted as cov-
ariates. Alcohol expectancies (e.g. AEQ), cannabis expect-
ancies (e.g. MEEQ) and simultaneous alcohol and
cannabis expectancies each acted as predictors. Age and
alcohol expectancy scores each demonstrated a main
effect. In addition, simultaneous expectancies for alcohol
and cannabis demonstrated a main effect. As predicted in
study hypotheses, simultaneous expectancies predicted
simultaneous alcohol and cannabis use beyond individ-
ual drug expectancies (See Table 6).
In the second linear regression equation, metric weight of
cannabis consumed per month when also using alcohol
served as the dependent variable. Again, lognormal trans-
formations improved the skew of the dependent variable
[24], and age and gender acted as covariates. The skewness
and kurtosis statistics were 1.3 and .36, respectively,
before lognormal transformations and .98 and -.52 after-
wards. Cannabis expectancies, alcohol expectancies and
simultaneous expectancies again acted as independent
variables. Only age and simultaneous expectancy scores
Table 4: Other Polydrug Consumption as measured by 
frequency (N = 2637)
Other Drug Combinations
Marijuana and hallucinogens 25%
Marijuana with sedatives 17%
Alcohol with hallucinogens 14%
Alcohol with sedatives 14%
Marijuana with cocaine 13%
Marijuana with stimulants 13%
Alcohol with Cocaine 12%
Alcohol with stimulants 11%
Stimulants with sedatives 4%
Cocaine with other stimulants 3%
Cocaine with sedatives 3%
Hallucinogens with sedatives 3%
Cocaine with hallucinogens 1%
Table 5: Bivariate correlations among Indicators of Cannabis and Alcohol Use
M e a s u r e 12345 6 7 8 9 1 0 1 1
1. Gender _
2. Age .02 _
3. All Drinks/Month .11** -.09** _
4. Only Drinks/Month .08** -.11** .55** _
5. Drinks/Can Month .06** .09** .68** .26** _
6. All Cann/Month -.01 -.13** .08** -.13** .20** _
7. Cann Only/Month -.01 -.15** .02 -.11** .14** .91** _
8. Cann/Drinks Month -.02 -.01 .20 -.03 .31** .60** .56** _
9. Alcohol Expectancies .06** -.22** .26** .20** .22** .01 -.01 .05* _
10. Cann Expectancies -.02 -.04* -.02 -.09** .04* .23** .24** .14** .05* _
11. Simult Expectancies .07** -.13** .18** .05* .25** .11** .08** .15** .53** .43** _
Note. * p < .05. ** p < .01; All Drinks/Month = Number alcoholic drinks consumed in the month; Only Drinks/Month = Number alcoholic drinks 
consumed when only drinking alcohol (e.g. no other substances); Drinks/Cann Month = Number alcoholic drinks consumed when also using 
cannabis; All Cann/Month = Metric weight of any cannabis used in the month; Cann Only/Month = Metric weight of cannabis consumed when only 
using cannabis; Cann/Drinks Month = Metric weight of cannabis consumed when also drinking alcohol in the month; Simult Expectancies = 
Combined simultaneous expectancy score.Substance Abuse Treatment, Prevention, and Policy 2006, 1:29 http://www.substanceabusepolicy.com/content/1/1/29
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demonstrated main effects in the prediction of metric
weight of cannabis consumed when also drinking. Thus
simultaneous expectancies again accounted for unique
variance beyond individual drug expectancy scores. Age
again demonstrated a significant effect (See Table 6). It is
notable that the authors examined the same equations
using only measures of use frequency (e.g. days per
month), and encountered no different findings.
A third equation examined frequency of simultaneous
use. Days per month in which respondents used alcohol
and cannabis simultaneously served as the dependent var-
iables. Again, age, gender, individual alcohol expectan-
cies, individual cannabis expectancies and simultaneous
expectancy scores each acted as predictors. Age and canna-
bis expectancies each predicted simultaneous use. Again,
simultaneous expectancies predicted simultaneous use
beyond variance accounted for by individual drug expect-
ancy measures (See Table 7). In this equation, unique var-
iance accounted for simultaneous expectancies was
notably larger than that of individual drug expectancies.
Discussion
In this study, simultaneous expectancies predicted simul-
taneous drug use quantity and frequency. Simultaneous
expectancies demonstrated the strongest main effect in
the prediction of number of days consuming alcohol and
cannabis simultaneously, as well as the number of alco-
holic drinks when also consuming cannabis. Age, alcohol
expectancies and simultaneous expectancies predicted
amount of cannabis consumed when drinking alcohol.
Effect size and power
Given the vast sample size, a potential limitation was the
clinical significance of effect size. Perhaps the large sample
size provided sufficient statistical power to reveal rela-
tively small findings with marginal clinical significance. It
is plausible that the extremely large online data sample
size may have resulted in the magnification of findings
that bear little real-world relevance. Yet effects are fre-
quently difficult to encounter in drug use data [e.g. [13]].
Although the effects associated with simultaneous expect-
ancies are small and do not consistently account for the
largest measures of unique variance in the regression
equations, the existence of statistically significant effect
merits further examination of the potential clinical signif-
icance of these findings.
Homogeneity of socio-economic status and ethnicity
Participants were largely Caucasian, educated and of mod-
erate socioeconomic status. Low socioeconomic status
[25] and low educational attainment [26] both correlate
Table 7: Linear regression: simultaneous alcohol and cannabis 
expectancies account for variance in the prediction of days per 
month using alcohol and cannabis simultaneously beyond 
individual alcohol expectancies or cannabis expectancies.
Variable ∆R2 R2 β t
Days Using Alcohol and Cannabis Simultaneously (df = 2539)
Age .014 .123 6.21**
Gender .001 .015 -.028 -1.42
AEQ .002 .017 .049 1.84
MEEQ .001 .018 .046 2.39*
Simultaneous Expectancies .017 .035 .179 6.74**
Note: Standardized regression coefficients (βs) derive from the step in 
which they are added to the equation.
*p < .05 **p < .01 _p = .05 Cannabis per month with alcohol = Metric 
weight of cannabis consumed when also drinking alcohol. Drinks per 
month with Cannabis = Number of alcoholic drinks when also 
consuming cannabis AEQ = Alcohol Expectancies; MEEQ = Cannabis 
Expectancies.
Table 6: Linear regression: simultaneous alcohol and cannabis expectancies account for variance in the prediction of simultaneous 
alcohol and cannabis use beyond individual alcohol expectancies or cannabis expectancies.
Variable ∆R2 R2 β t
Simultaneous Alcohol and Cannabis Use Drinks Per Month (Log Normal; df = 2517)
Age .005 -067 -3.66**
Gender .001 .006 .036 1.87
AEQ .008 .014 .167 4.85**
MEEQ .004 .018 .065 3.39**
Simultaneous Expectancies .020 .038 .185 7.60**
Simultaneous Alcohol and Cannabis Use Cannabis Per Month (Log Normal; df = 2552)
Age .019 -.143 -7.12**
Gender .000 .019 -.021 -1.09
AEQ .002 .021 -.066 2.43*
MEEQ .001 .022 .026 1.34
Simultaneous Expectancies .003 .025 .069 2.59*
Note: Standardized regression coefficients (βs) derive from the step in which they are added to the equation.
*p < .05 **p < ..01 _p = .05 Cannabis per month with alcohol = Metric weight of cannabis consumed when also drinking alcohol. Drinks per month 
with Cannabis = Number of alcoholic drinks when also consuming cannabis AEQ = Alcohol Expectancies; MEEQ = Cannabis Expectancies.Substance Abuse Treatment, Prevention, and Policy 2006, 1:29 http://www.substanceabusepolicy.com/content/1/1/29
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with drug use in previous research. Individuals with lower
income or education may have evidenced a positive link
between single substance expectancies and use regardless
of simultaneous alcohol consumption. A more ethnically
diverse sample may have demonstrated different findings
as well.
Sample selection biases
Participants belonged to the National Organization for
the Reform of Marijuana Laws or the Marijuana Policy
Project. Individuals in this group were more likely to be
aligned with the organization's mission of cannabis activ-
ism. Individuals belonging to these organizations may
have been more likely to report positive associations with
cannabis, accounting for higher cannabis expectancies in
the online data sample. Also, participants belonging to
these organizations may have been less likely to report
problem-inducing cognitions associated with cannabis.
We know of no research that would indicate that mini-
mizing of cannabis problems would impact reports of
expectancies. Respondents continued to report considera-
ble use. Previous studies have successfully identified alco-
hol and cannabis problems in similar online populations
[see [13]]. Thus this potential limitation does not repre-
sent an insurmountable barrier to data interpretation.
These findings may offer greatest importance for those
individuals who are frequent and/or heavy users of canna-
bis and alcohol. As previously mentioned, a more ethni-
cally diverse sample would have offered more
generalizable findings. Still, whereas the present sample
provided a cross-section of individuals who consume the
two drugs and demonstrate associated problems, we con-
tend that these data offer some generalizability for indi-
viduals who consume cannabis and alcohol
simultaneously.
Measurement
Whereas this study established a new measure of simulta-
neous alcohol and cannabis expectancies, it is possible
that this measure introduced problems to the study. High
disagreement between the first and second administration
of items used in the MEEQ could indicate a problem with
the measure. Reordering of items (e.g. MEEQ before AEQ)
could significantly alter measure scores. Inherently, the
simultaneous expectancy measure was lengthy and repeti-
tious. It is possible that some participants encountered the
measure as burdensome. During pilot testing, respond-
ents indicated that although the measure was long and
repetitious, these features did not preclude accurate com-
pletion of the survey. However, it is possible that the
actual study respondents encountered the measure differ-
ently than pilot test participants.
Furthermore, the current administration of the simultane-
ous expectancies measure is likely the first in an iterative
development process. The creation of a new measure typ-
ically requires numerous administrations and intensive
research into the measure validity and reliability. Further
research geared toward developing a more comprehensive
measure of simultaneous alcohol and cannabis expectan-
cies could provide greater evidence regarding unique
expectancies for increased drug effects.
Also, issues of self-report may have obstructed findings in
these data. Although data collection was anonymous,
some participants may have encountered self-presenta-
tional issues that prevented them from reporting sub-
stance use. Although past research suggested that online
measures elicited greater reports of drug consumption
compared to laboratory-based measures [27], respond-
ents may have been hesitant to report drug use and espe-
cially illicit drug use. It is unclear whether those who
suffer the worst negative consequences of drugs are will-
ing to disclose all symptoms and the full extent of their
drug use in an Internet context. Still, the aforementioned
limitations are common to many studies on these topics
[see [28]], and may not present insurmountable barrier to
interpretation of the data.
Experimental manipulation
As with any moderator that has not been manipulated
experimentally, findings in this study could have arisen
from drug use correlates rather than substance use itself.
Personality traits, family history, genetics, or a plethora of
other factors that correlate with alcohol and cannabis use
may have actually served as the impetus for simultaneous
alcohol and cannabis use. For example, sensation seekers
may be more likely to score higher on drug expectancy
measures and engage in more polydrug use. Perhaps sen-
sation seeking, a known correlate of cannabis use [29], or
its genetic correlates were actual factors underlying simul-
taneous alcohol and cannabis use. Nevertheless, the idea
that unique expectancies regarding simultaneous use
leads to increased simultaneous polydrug expectancies
seems tenable.
Implications
Whereas the concept of simultaneous drug expectancies is
a relatively new adaptation of the existing literature on
expectancies, additional study could assist researchers in
the development of this potentially useful research con-
struct and measurement tool. The second administration
of MEEQ items came toward the end of the study meas-
ures. Perhaps moderate correlations between first and sec-
ond administrations of MEEQ items suggest participant
fatigue toward the end of the study. Future studies may
lessen participant burden by abbreviating the scale or
dividing test administration into two sessions. Examina-
tion of other relevant subscale items from the AEQ and
MEEQ may merit further exploration. The recommendedSubstance Abuse Treatment, Prevention, and Policy 2006, 1:29 http://www.substanceabusepolicy.com/content/1/1/29
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procedure of reverse scoring negative items in the MEEQ
may not yield items comparable to positive items on the
AEQ. That is, the reverse score of a negative statement may
not be the ideological analog to a positive statement.
Future research may wish to explore rewriting items from
the MEEQ's global scale under the supervision of the
scale's authors.
Finally, although a combined expectancy score provided
superior predictive powers than its component scales (e.g.
alcohol alters experiences with marijuana; marijuana
alters experiences with alcohol) in this study, future
researchers may wish to examine these components sepa-
rately. Perhaps further study will reveal different out-
comes associated with the belief that one substance
impacts the other to a greater extent.
Conclusion
If simultaneous expectancies offer a sound predictor of
simultaneous drug use and, ultimately, problems,
researchers may wish to integrate these findings into drug
treatment and prevention efforts, including intervention
attempts to decrease positive drug expectancies [e.g.
[30,31]]. Research examining specific expectancies (e.g.
simultaneous alcohol and cannabis expectancies for
aggression) could explore simultaneous expectancies'
capacity to predict particular simultaneous drug use con-
sequences (e.g. drug-related violence).
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